ARC-8: Phase 1/1b randomized study of quemliclustat + gemcitabine/nab-paclitaxel ± zimberelimab in patients with treatment-naive metastatic pancreatic adenocarcinoma Meeting Abstract
| Authors: | Wainberg, Z. A.; Manji, G. A.; Bahary, N.; Ulahannan, S. V.; Pant, S.; Uboha, N. V.; Oberstein, P. E.; Lu, L. H.; Scott, J. R.; Wu, W.; Rhee, J.; Nuyten, D. S. A.; O'Reilly, E. M. |
| Abstract Title: | ARC-8: Phase 1/1b randomized study of quemliclustat + gemcitabine/nab-paclitaxel ± zimberelimab in patients with treatment-naive metastatic pancreatic adenocarcinoma |
| Meeting Title: | 2024 ASCO Gastrointestinal Cancers Symposium |
| Keywords: | 261-492-199-2823; 261-492-3532-2370-7650-2700; 283-2494 |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 42 |
| Issue: | 3 Suppl. |
| Meeting Dates: | 2024 Jan 18-20 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2024-01-20 |
| Language: | English |
| ACCESSION: | WOS:001266680500139 |
| DOI: | 10.1200/JCO.2024.42.3_suppl.665 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 665 -- Source: Wos |
